Breanne Everett - 2016 Governor General's Innovation Awards Winner
This article was originally written and submitted as part of a Canada 150 Project, the Innovation Storybook, to crowdsource stories of Canadian innovation with partners across Canada. The content has since been migrated to Ingenium’s Channel, a digital hub featuring curated content related to science, technology and innovation.
Dr. J. Breanne Everett is the CEO and co-founder of Orpyx, as well as a medical doctor and resident in plastic and reconstructive surgery at the University of Calgary.
Breanne Everett co-founded Orpyx Medical Technologies to develop her idea for shoe insoles that prompts patients with diabetic foot conditions to move their feet to improve blood flow. This unique, wearable technology has improved users’ quality of life and reduced health care costs by decreasing the risks of sores, infection and amputation caused by diabetes-related nerve damage and poor circulation. She was named one of Avenue Magazine’s Top 40 Under 40 in 2012, and the University of Calgary’s Graduate of the Last Decade in 2014. She is a Loran National Scholar, who serves as an active member of the Loran Alumni Community, and is a member of the scientific review board of the Pedorthic Research Association of Canada.
On May 18, 2016, Ms. Everett was one of the first six individuals to receive the inaugural Governor General’s Innovation Awards.
Announced in June 2015, the Governor General’s Innovation Awards inspire Canadians to embrace innovation and to emulate innovative, entrepreneurial risk-takers who have developed new or better ways of creating value and who are having a meaningful impact on our quality of life. For more information, visit https://innovation.gg.ca/.
Breanne Everett hopes to make a huge dent in diabetic foot care. The co-founder of Orpyx Medical Technologies created a unique, wearable technology that has improved users’ quality of life and reduced health care costs by decreasing the risks of sores, infection and amputations caused by the diabetes-related nerve damage and poor circulation. Watch this video to learn more about this Canadian innovation.